1233697-21-6

Basic information

• Product Name: 6-chloro-2-(4-chloro-phenyl)-3-fluoro-pyridine
• Synonyms: 6-chloro-2-(4-chloro-phenyl)-3-fluoro-pyridine
• CAS NO: 1233697-21-6
• Molecular Weight: 242.08
• Mol File: 1233697-21-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 6-chloro-2-(4-chloro-phenyl)-3-fluoro-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-chloro-2-(4-chloro-phenyl)-3-fluoro-pyridine(1233697-21-6)
• EPA Substance Registry System: 6-chloro-2-(4-chloro-phenyl)-3-fluoro-pyridine(1233697-21-6)

Safety Data

• Hazardous Substances Data: 1233697-21-6(Hazardous Substances Data)

Upstream product

• 1233697-19-2 2-(4-chlorophenyl)-3-fluoropyridine 1-oxide 
• 1679-18-1 4-Chlorophenylboronic acid 
• 52208-50-1 2,6-dichloro-3-fluoropyridine 
• 189281-48-9 2,4-dichloro-5-fluoropyridine 

Downstream Products

• 1364677-55-3 6-chloro-2-(4-chloro-phenyl)-3-(2,2,2-trifluoro-ethoxy)-pyridine 
• 1364677-57-5 6-(4-chloro-phenyl)-5-(2,2,2-trifluoro-ethoxy)-pyridine-2-carboxylic acid methyl ester 
• 1364677-59-7 6-(4-chlorophenyl)-5-(2,2,2-trifluoroethoxy)-2-pyridinecarboxylic acid 
• 1382465-66-8 2-(4-chloro-phenyl)-3-fluoro-6-(2,2,2-trifluoro-ethoxy)-pyridine 

Relevant articles and documents

HETEROARYLMETHYL AMIDES

The present invention relates to compounds of the formula I wherein A1, A2, A3 and R1 to R8 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.

HETEROARYLMETHYL AMIDES

The present invention relates to compounds of the formula wherein A1, A2, A3 and R1 to R8 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.

7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES

Compounds of Formula I: (I) in which A, A1, R1, R7a, R7b, R8 and R10 have the meanings given in the specification, are DP2 receptor inhibitors useful in the treatment of useful in the treat